SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-17-012085
Filing Date
2017-06-30
Accepted
2017-06-30 16:03:08
Documents
1
Period of Report
2017-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rdgdoc.html 4/A  
1 FORM 4/A rdgdoc.xml 4/A 3882
  Complete submission text file 0001437749-17-012085.txt   5559
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address
Kalergis David G (Reporting) CIK: 0001663574 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37942 | Film No.: 17942078